2022 Volume 55 Issue 3 Pages 201-207
The patient was an 88‒year‒old male who had been undergoing hemodialysis (HD) for 8 years at our hospital. His family members, who were living with him, were infected with the SARS‒CoV‒2 alpha variant. Subsequently, he was also found to have been infected. No symptoms of respiratory system were observed on admission. Thereafter, hypoxemia due to pneumonia (severity classification： moderate Ⅱ) developed. Supportive therapy with nasal oxygen administration to maintain an SpO2 of ≥93％, dexamethasone (6.6 mg/day for 10 days) and remdesivir (100 mg/HD session, 3 times) were started, resulting in his recovery from COVID‒19. It was uncertain whether remdesivir can be used safely in patients with COVID‒19 undergoing hemodialysis. However, in this case, which involved an elderly patient, administering remdesivir at a dose of 100 mg 4 hours before each HD session was useful.
